”He signalled he wanted to look at companies or collaborations in Australia that were developing their own intellectual property or had access to it from others and were capable of completing all the steps in mRNA production.”
this is from the SMH article. I think this fits with IDT and the collaboration they have with Monash University.
”He signalled he wanted to look at companies or collaborations...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.010(8.70%) |
Mkt cap ! $53.69M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.0¢ | 12.0¢ | $99.94K | 818.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 320 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 53148 | 2 |
View Market Depth
| Last trade - 15.48pm 09/08/2024 (20 minute delay) ? |
| IDT (ASX) Chart |